Backed by more than a dozen prominent investors, the startup is advancing into human testing a drug it believes capable of ...

In a drug discovery career spanning more than two decades, Alex Lugovskoy has seen a lot of antibodies come and go. The vast majority of them work by inhibiting a cellular function. Lugovskoy, now the ...

Financing co-led by Sanofi Ventures and Janus Henderson Investors, with participation from new investors Deep Track Capital, EcoR1 Capital, Logos Capital, Balyasny Asset Management L.P., Woodline Part ...

Joel Levinson was in his second year of architecture studies at the University of Pennsylvania when he overheard two students speaking as if they were up to no good. These being fellow building buffs, ...

Diagonal Therapeutics is taking shape, launching with $128 million and backed by the likes of BVF Partners, Atlas Venture and RA Capital to develop a pipeline of antibody agonists. The company will ...

Over the last decade, officials have tried a series of steps to rein in cars on Los Angeles streets. They turned parking spaces into micro-parks, converted street corners into trendy plazas and ...